Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
12
92%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Terminated(2)
Other(1)

Detailed Status

Completed10
Withdrawn2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (7.7%)
N/A12 (92.3%)

Trials by Status

withdrawn215%
completed1077%
unknown18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13